Kirsner JB, Shorter RG: Inflammatory Bowel Disease . Philadelphia, Lea & Febiger Publishers, 1975;.
Kirsner JB: Observations on the etiology and pathogenesis of inflammatory bowel disease , in Bockus HL (ed): Gastroenterology , ed 4. Philadelphia, WB Saunders Co, 1976;, vol 2, pp 521-539.
Kirsner JB: Inflammatory bowel disease: Considerations of etiology and pathogenesis . Am J Gastroenterol 69:253-271, 1978;.
Shorter RG, Shepard DAE: Frontiers in inflammatory bowel diseases: Extraintestinal complications of inflammatory bowel disease: Are these natural experiments instructive? Am J Dig Dis 20:639-670, 1975;.
Farmer RG, Hawk WA, Turnbull RB Jr: Clinical patterns in Crohn's disease: A statistical study of 615 cases . Gastroenterology 68:627-635, 1975;.
Greenstein AJ, Janowitz HD, Sachar DB: The extraintestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients . Medicine 55:401-412, 1976;.
Drenick EJ, Ament ME, Finegold SM, et al: Bypass enteropathy: Intestinal and systemic manifestations following small bowel bypass . JAMA 236:269-272, 1976;.
Roth JLA, Valdes-Dapena A, Stein GN, et al: Toxic megacolon in ulcerative colitis . Gastroenterology 37:239-255, 1959;.
Norland CC, Kirsner JB: Toxic dilation of the colon (toxic megacolon) . Medicine 48:229-250, 1969;.
Kappelman WB, Burrell M, Toffler R: Megacolon associated with celiac sprue: Report of four cases and review of the literature . AJR 128:65-68, 1971;.
Goldgraber MB, Kirsner JB: Carcinoma and ulcerative colitis—a clinicalpathological study: I. Cancer deaths . Gastroenterology 34:809-839, 1958;.
Goldgraber MB, Kirsner JB: Carcinoma and ulcerative colitis—a clinicalpathological study: II. Statistics . Gastroenterology 34:840-846, 1958;.
Goldgraber MD, Kirsner JB: Carcinoma and ulcerative colitis—a clinicalpathological study: III. Survivors . Gastroenterology 36:613-630, 1959;.
Goldgraber MB, Kirsner JB: Carcinoma of the colon in ulcerative colitis . Cancer 17:657-665, 1974;.
Edwards FC, Truelove SC: The course and prognosis of ulcerative colitis: IV. Carcinoma of the colon . Gut 5:15-22, 1964;.
Morson BC, Pang LS: Rectal biopsy as an aid to cancer control in ulcerative colitis . Gut 8:423-434, 1967;.
De Vroede GJ, Taylor WF, Saucer WG, et al: Cancer risk and life expectancy of children with ulcerative colitis . N Engl J Med 285:17-21, 1971;.
Lennard-Jones JE, Morson BC, Ritchie JK, et al: Cancer in colitis: Assessment of the individual risk by clinical and histological criteria . Gastroenterology 73:1280-1289, 1977;.
Yardley JH, Bayless TM, Diamond MP: Cancer in ulcerative colitis . Gastroenterology 76:221-225, 1979;.
Reddy BS, Martin CW, Wynder EL: Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis: A high risk group of development of colon cancer . Cancer Res 37:1697-1701, 1977;.
Morowitz DA, Block GE, Kirsner JB: Adenocarcinoma of the ileum complicating chronic regional enteritis . Gastroenterology 55:397-402, 1968;.
Lightdale CJ, Sternberg SS, Posner G, et al: Carcinoma complicating Crohn's disease . Am J Med 59:262-268, 1975;.
Weedon DD, Shorter RG, Ilstup DM, et al: Crohn's disease and cancer . N Engl J Med 289:1099-1103, 1975;.
Goodman MJ, Skinner JM, Truelove SC: Abnormalities in the apparently normal bowel mucosa in Crohn's disease . Lancet 1:275-278, 1976;.
Allan R, Steinberg DM, Dixon K, et al: Changes in the bidirectional sodium flux across the intestinal mucosa in Crohn's disease . Gut 16:201-204, 1975;.
Dunne WT, Cook WT, Allan RM: Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract . Gut 18:290-294, 1977;.
Gerson CD, Fabry EM: Ascorbic acid deficiency and fistula formation in regional enteritis . Gastroenterology 67:428-433, 1974;.
Filipsson I, Haltern L, Lindstedt G, et al: The metabolic consequences of surgery in Crohn's disease . Scand J Gastroenterol 13:471-479, 1978;.
Moossa AR, Hall AW, Skinner DB, et al: Effect of 50% small bowel resection on gastric secretory function in rhesus monkeys . Surgery 80:208-213, 1976;.
Acheson ED: An association between ulcerative colitis, regional enteritis and ankylosing spondylitis . Q J Med 29:489-499, 1969;.
McEwen C, Lingg C, Kirsner JB, et al: Arthritis accompanying ulcerative colitis . Am J Med 33:923-941, 1962;.
Bowen G, Kirsner JB: The arthritis of ulcerative colitis and regional enteritis ("intestinal arthritis") . Med Clin North Am 49:17-32, 1965;.
Wands JR, LaMont JT, Mann E, et al: Arthritis associated with intestinal bypass procedure for morbid obesity . N Engl J Med 294:121-124, 1976;.
Hodgson HJF, Potter BJ, Jewell DP: Immune complexes in ulcerative colitis and Crohn's disease . Clin Exp Immunol 29:187-196, 1977;.
Flasse R, Lurhume AZ, Cambiaso CL: Circulating immune complexes and disease activity in Crohn's disease . Gut 19:611-617, 1978;.
Kleckner MS, Stauffer MH, Bargen JA, et al: Hepatic lesions in the living patient with chronic ulcerative colitis as demonstrated by needle biopsy . Gastroenterology 22:13-33, 1952;.
Mistilis SP, Skyring AP, Goulston SJM: Pericholangitis and ulcerative colitis: I. Pathology, etiology and pathogenesis. II. Clinical aspects . Ann Intern Med 63:1-26, 1965;.
Eade MN: Liver disease in ulcerative colitis: I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy . Ann Intern Med 72:475-487, 1970;.
Eade MN: Liver disease in ulcerative colitis: II. The long-term effect of colectomy . Ann Intern Med 72:489-497, 1970;.
Dordal E, Glagov S, Kirsner JB: Hepatic lesions in chronic inflammatory bowel disease . Gastroenterology 52:239-253, 1967;.
Baker AL, Kaplan MM, Norton RA, et al: Gallstones in inflammatory bowel disease . Am J Dig Dis 19:109-112, 1974;.
Warren KE, Athanassiades S, Monge JI: Primary sclerosing cholangitis . Am J Surg 111:23-38, 1966;.
Morowitz DA, Glagov S, Dordal E, et al: Carcinoma of the biliary tract complicating chronic ulcerative colitis . Cancer 27:356-361, 1971;.
Kelley ML Jr: Skin lesions associated with chronic ulcerative colitis . Am J Dig Dis 7:255-272, 1962;.
McCallum DI, Kinmont PDC: Dermatological manifestations of Crohn's disease . Br J Dermatol 80:1-8, 1968;.
Gelernt IM, Kreel J: Pyoderma gangrenosum in ulcerative colitis: Prevention of the gangrenous component . Mt Sinai J Med 43:467-470, 1976;.
Crawford SE, Sherman R, Favara B: Pyoderma gangrenosum with response to cyclophosphamide therapy . J Pediatr 71:255-258, 1967;.
Kirsner JB, Sheffner L, Palmer WL: Studies on amino acid excretion: V. Chronic ulcerative colitis and regional enteritis . J Clin Invest 39:874-880, 1950;.
Beeken WL, Busch HJ, Sylvester DL: Intestinal protein loss in Crohn's disease . Gastroenterology 62:207-215, 1972;.
Dyer NH, Child JA, Mollin DL, et al: Anemia in Crohn's disease . Q J Med 44:419-436, 1972;.
Earnest DL: Enteric hyperoxaluria . Adv Intern Med 24:407-427, 1979;.
Franklin JL, Rosenberg IH: Impaired folic acid absorption in inflammatory bowel disease: Effects of salicylazosulfapyridine (Azulifidine) . Gastroenterology 64:517-525, 1973;.
Benson RE, Bargen JA: Chronic ulcerative colitis as a cause of retarded sexual and gonadic development . Gastroenterology 1:147-159, 1943;.
McCaffrey TD, Nasr K, Lawrence AM, et al: Severe growth retardation in children with inflammatory bowel disease . Pediatrics 42:386-393, 1970;.
Berger M, Griebetz D, Korelitz BI: Growth retardation in children with ulcerative colitis: The effect of medical and surgical therapy . Pediatrics 55:459-467, 1975;.
Kirschner BS, Voinchet OH, Rosenberg IH: Growth retardation in inflammatory bowel disease . Gastroenterology 75:504-511, 1978;.
Basu MK, Asquith P, Thompson RA, et al: Oral manifestations of Crohn's disease . Gut 16:249-254, 1975;.
Li Volsi VA, Jaretzki A III: Granulomatous esophagitis: A case of Crohn's disease limited to the esophagus . Gastroenterology 64:313-319, 1972;.
Danzi JT, Farmer RG, Sullivan BH Jr, et al: Endoscopic features of gastroduodenal Crohn's disease . Gastroenterology 70:9-13, 1976;.
Das KM, Eastwood MA, McManus JPA, et al: Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype . N Engl J Med 289:491-495, 1973;.
Schroder H, Evans DAP: Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects . Gut 13:278-284, 1972;.
Goldstein MJ, Gelzayd EA, Kirsner JB: Some observations on hazards of corticosteroid therapy in patients with inflammatory disease . Trans Am Acad Ophthalmol Otolaryngol 71:254-261, 1967;.
Gelzayd EA, Breuer RI, Kirsner JB: Nephrolithiasis in inflammatory bowel disease . Am J Dig Dis 13:1027-1034, 1968;.
Graef V, Baggenstoss AH, Sauer WG, et al: Venous thrombosis occurring in non-specific ulcerative colitis . Arch Intern Med 117:377-382, 1966;.
Block GE, Enker WE, Kirsner JB: Significance and treatment of occult obstructive uropathy complicating Crohn's disease . Ann Surg 178:322-332, 1973;.
Mukhopadhyay D, Nasr K, Grossman BJ, et al: Pericarditis associated with inflammatory bowel disease . JAMA 211:1540, 1970;.